Newsroom

Labcorp News

To find out more about additional news of interest from Labcorp, see some of the latest updates here. 


January 13, 2021

Media Statement: Labcorp Political Contributions

Labcorp does not make contributions to federal political candidates. Labcorp does have a Political Action Committee (PAC). The Labcorp PAC contributes to both Democrats and Republicans who support science, innovation, and appropriate coverage and reimbursement. The Labcorp PAC Executive Committee has established guidelines for contributions to…

Read more »
Labcorp News
January 4, 2021

Media Statement: Tracking Mutations of the SARS CoV2

Labcorp has been regularly tracking mutations of the coronavirus throughout the pandemic, including a new variant strain of SARS-CoV-2 (VOC 202012/01 or B.1.1.7) in the UK and more recently in the US, to determine the impact it would have on our PCR test sensitivity. To date, we have not seen any impact.

Read more
Labcorp News
December 18, 2020

Labcorp and Rush University System for Health Enter into a Partnership Focused on Laboratory, Clinical Trial and Data Service

Labcorp now serves as the primary lab for the RUSH network as it embarks on a comprehensive clinical trials relationship Labcorp (NYSE: LH) has entered into a comprehensive partnership with Rush University System for Health (RUSH) to serve as the primary lab for Chicago-based hospitals and physicians in the RUSH network. RUSH will also operate as…

Read more »
Labcorp News
December 16, 2020

Labcorp Evolves Its Brand to Showcase Its Role as a Trusted Source in Healthcare

New Brand Identity Highlights the Power of its Combined Businesses  BURLINGTON, N.C., Dec. 16, 2020 — Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, is evolving its brand identity to highlight the pivotal role the company plays in healthcare and showcase the power…

Read more »
Labcorp News
December 16, 2020

Covance, Labcorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

Company enhances patient recruitment by employing patient data for deeper visibility into test patterns and patient groups LONDON, U.K. — December 16, 2020 — Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes Labcorp’s drug development business, Covance, with the 2020 Global CRO…

Read more »
Labcorp News
November 29, 2020

CancerIQ Officially Launches Lab Network to Increase Awareness and Accelerate Adoption of Genetic Testing

Anchor members include Eurofins EGL Genetic Diagnostics, Eurofins NTD, Invitae, LabCorp and Myriad Genetics CHICAGO, November 19, 2020 — CancerIQ, an enterprise precision health platform for cancer, has formed a network of trusted genetic labs to streamline and inform the genetic test ordering process. The CancerIQ Lab Network increases access to…

Read more »
Labcorp News

Media Information

For Media Inquiries


Christopher Allman-Bradshaw
or Rachael Valdez
Phone: 336-436-8263
Email: [email protected]

For Investor Relations


Clarissa Willett 
Phone: 336-436-5076
Email: [email protected]

Digital Assets


If you use any of this imagery or footage, please use Photo/Video credit: Labcorp
Download B-roll
Download Images